- 0
- 9
What changed
Each line against the same period a year earlier, as the company reported both in its latest filing. The math is under every line.
Latest quarter vs the same quarter a year earlier
10-Q filed 2026-09-10 ↗| Quarter ended | 2025-08-03 | 2026-08-02 | Change |
|---|---|---|---|
| Revenue(29,591 − 15,952) ÷ |15,952| × 100 = +85.5% ($ millions) | $16.0B | $29.6B | +85.5% |
| Operating income(15,955 − 5,887) ÷ |5,887| × 100 = +171.0% ($ millions) | $5.9B | $16.0B | +171.0% |
| Net income(715 − 1,196) ÷ |1,196| × 100 = −40.2% ($ millions) | $1.2B | $715.0M | −40.2% |
| Diluted earnings per share(2.68 − 0.85) ÷ |0.85| × 100 = +215.3% ($ a share) | $0.85 | $2.68 | +215.3% |
| Diluted share count (weighted)(4,887 − 4,860) ÷ |4,860| × 100 = +0.6% (millions of shares) | 4.86B | 4.89B | +0.6% |
| Research and development(2,895 − 3,050) ÷ |3,050| × 100 = −5.1% ($ millions) | $3.0B | $2.9B | −5.1% |
Latest fiscal year vs the year before
10-K filed 2025-12-18 ↗| Year ended | 2024-11-03 | 2025-11-02 | Change |
|---|---|---|---|
| Revenue(63,887 − 51,574) ÷ |51,574| × 100 = +23.9% ($ millions) | $51.6B | $63.9B | +23.9% |
| Operating income(25,484 − 13,463) ÷ |13,463| × 100 = +89.3% ($ millions) | $13.5B | $25.5B | +89.3% |
| Net income(5,895 − 14,082) ÷ |14,082| × 100 = −58.1% ($ millions) | $14.1B | $5.9B | −58.1% |
| Diluted earnings per share(4.77 − 1.23) ÷ |1.23| × 100 = +287.8% ($ a share) | $1.23 | $4.77 | +287.8% |
| Diluted share count (weighted)(4,853 − 4,778) ÷ |4,778| × 100 = +1.6% (millions of shares) | 4.78B | 4.85B | +1.6% |
| Research and development(10,977 − 9,310) ÷ |9,310| × 100 = +17.9% ($ millions) | $9.3B | $11.0B | +17.9% |
| Operating cash flow(27,537 − 19,962) ÷ |19,962| × 100 = +37.9% ($ millions) | $20.0B | $27.5B | +37.9% |
Metrics from the filings
Each value carries the period it covers and the form it was reported in.
| Metric | Value | Period end | Form |
|---|---|---|---|
| Revenue | $63.9B | 2025-11-02 | 10-K |
| Net income | $5.9B | 2024-11-03 | 10-K |
| Operating cash flow | $27.5B | 2025-11-02 | 10-K |
| Research and development | $11.0B | 2025-11-02 | 10-K |
| Total assets | $171.1B | 2025-11-02 | 10-K |
| Cash and cash equivalents | $16.2B | 2025-11-02 | 10-K |
| Shares outstanding | 4.77B | 2026-08-28 | 10-Q |
| Revenue | $29.6B | 2026-08-02 | 10-Q |
| Net income | $715.0M | 2019-08-04 | 10-Q |
| Revenue, prior year | $51.6B | 2024-11-03 | 10-K |
| Net income, prior year | $14.1B | 2023-10-29 | 10-K |
| Revenue, same quarter prior year | $16.0B | 2025-08-03 | 10-Q |
Videos on AVGO
No video on AVGO yet. Follow the company and you will hear when there is one.